In a controlled double-blind cross-over trial in 10 patients comprising six with open-angle
glaucoma, three with closed-angle glaucoma, and one with ocular hypertension, a single …

Oral atenolol (25 mg twice daily and 50 mg and 100 mg once daily) and placebo were tested
as additional therapy in a double-masked, randomised, cross-over study. Twenty-four …

The ocular hypotensive effect of single oral doses of (a) atenolol (50 mg),(b) acetazolamide
(500 mg),(c) atenolol (50 mg) and acetazolamide (500 mg) in combination, and (d) vehicle …

Atenolol (Tenormin or ICI 66082) is a new beta-adrenergic blocking drug, unique in being
cardio-selective and in having no intrinsic sympathomimetic or membrane activity. In a …

The effect of long-term application of 4% atenolol eye drops has been studied in patients
with either glaucoma or ocular hypertension. In some patients who show a good initial …

Placebo and propranolol (Inderal) in doses of 20, 40, and 80 mg were given in a single-blind
test to two groups of six ocular hypertensives. The groups consisted of patients with an …

Guttae atenolol 4%(Tenormin), a pure beta1-blocking (ie, cardioselective) drug, produced a
median overall fall of 5-6 mmHg (range 3-2 to 13-2 mmHg) in the first tonometrised eyes of 7 …

Forty six normal volunteers were randomly assigned in double-blind fashion to once daily
orally administered nadolol 10, 20, 40, or 80 mg for five days. Significant and dose related …

One of the most intriguing and daily recurring problems in the ophthalmological practice is
glaucoma; for as we know every glaucoma patient has to face the fact their eye sight is …

Propranolol, a β‐adrenergic blocking agent, was given by mouth to 22 patients with elevated
IOP resistent to conventional medical treatment or where conventional treatment was …